Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) EPS without NRI: ₺-1.53 (TTM As of Mar. 2026)


IST:SELEC Selcuk Ecza Deposu Ticaret ve Sanayi AS IST:SELEC
79 GF Score
Price ₺223.00
GF Value ₺87.25
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Selcuk Ecza Deposu Ticaret venayi AS EPS without NRI?

Selcuk Ecza Deposu Ticaret venayi AS IST:SELEC +6.80% 79 EPS without NRI is ₺-1.53 as of Mar. 2026. GuruFocus rates IST:SELEC with a GF Score™ of 79/100 and a GF Value™ of ₺87.25 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 102 Medical Distribution companies, Selcuk Ecza Deposu Ticaret venayi AS ranks worse than 980391.18% on this metric.

Selcuk Ecza Deposu Ticaret venayi AS's earnings per share without non-recurring items for the three months ended in Mar. 2026 was ₺1.99. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was ₺-1.53.

During the past 12 months, Selcuk Ecza Deposu Ticaret venayi AS's average earnings per share (NRI) Growth Rate was -258.30% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Selcuk Ecza Deposu Ticaret venayi AS's EPS without NRI or its related term are showing as below:

During the past 13 years, Selcuk Ecza Deposu Ticaret venayi AS's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 42.00% per year. The lowest was -61.10% per year. And the median was 12.70% per year.

IST:SELEC's 3-Year EPS without NRI Growth Rate is not ranked *
in the Medical Distribution industry.
Industry Median: 3.65
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Selcuk Ecza Deposu Ticaret venayi AS's EPS (Diluted) for the three months ended in Mar. 2026 was ₺2.48. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₺1.90.

Selcuk Ecza Deposu Ticaret venayi AS's EPS (Basic) for the three months ended in Mar. 2026 was ₺2.48. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₺1.90.


Selcuk Ecza Deposu Ticaret venayi AS  (IST:SELEC) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Selcuk Ecza Deposu Ticaret venayi AS EPS without NRI Related Terms


Selcuk Ecza Deposu Ticaret venayi AS EPS without NRI Historical Data

* Premium members only.

The historical data trend for Selcuk Ecza Deposu Ticaret venayi AS's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Selcuk Ecza Deposu Ticaret venayi AS EPS without NRI Chart

Selcuk Ecza Deposu Ticaret venayi AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.48 0.96 0.06 2.75 -4.62

Selcuk Ecza Deposu Ticaret venayi AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.28 -1.44 -1.28 -0.80 1.99

IST:SELEC vs MCK, CAH, COR: EPS without NRI Comparison

For the Medical Distribution subindustry, Selcuk Ecza Deposu Ticaret venayi AS's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Selcuk Ecza Deposu Ticaret venayi AS PE Ratio without NRI vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Selcuk Ecza Deposu Ticaret venayi AS's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Selcuk Ecza Deposu Ticaret venayi AS's PE Ratio without NRI falls into.


IST:SELEC
79GF Score
Selcuk Ecza Deposu Ticaret ve Sanayi AS IST:SELEC
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Selcuk Ecza Deposu Ticaret venayi AS EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺-1.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of ₺-1.53 mean?
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) has a EPS without NRI of ₺-1.53 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. According to the industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #999999 out of 102 companies in the Medical Distribution industry.
Is Selcuk Ecza Deposu Ticaret venayi AS's EPS without NRI too high?
Selcuk Ecza Deposu Ticaret venayi AS's current EPS without NRI is ₺-1.53. Based on the distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #999999 out of 102 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Selcuk Ecza Deposu Ticaret venayi AS has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selcuk Ecza Deposu Ticaret venayi AS's EPS without NRI compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #999999 out of 102 companies for EPS without NRI. This places Selcuk Ecza Deposu Ticaret venayi AS in the lower half of its industry. The industry median EPS without NRI is 3.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Distribution company?
The median EPS without NRI among Medical Distribution companies is 3.65, based on 102 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. For the Medical Distribution industry, the median EPS without NRI is 3.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selcuk Ecza Deposu Ticaret venayi AS's current EPS without NRI is ₺-1.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selcuk Ecza Deposu Ticaret venayi AS stock overvalued right now?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺87.25, compared to a current price of ₺223.00 — trading 155.6% above its estimated fair value. The current EPS without NRI is ₺-1.53. Selcuk Ecza Deposu Ticaret venayi AS's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC), the current EPS without NRI is ₺-1.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Overvalued in 2026?

Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS stock appears to be overvalued. The current stock price of ₺223.00 is trading 155.6% above its estimated GF Value™ of ₺87.25. GuruFocus considers Selcuk Ecza Deposu Ticaret venayi AS to be Significantly Overvalued.

Key valuation signals for IST:SELEC:

  • EPS without NRI: ₺-1.53
  • GF Value™: ₺87.25 vs. price of ₺223.00 (155.6% above fair value)
  • GF Score™: 79/100 with 8 warning signs

No single metric tells the full story. See the IST:SELEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Selcuk Ecza Deposu Ticaret venayi AS Business Description

Address Altunizade Mah. Kusbakisi Cad. No: 37, Nakkastepe, Istanbul, TUR, 34662
Selcuk Ecza Deposu Ticaret ve Sanayi AS and its subsidiaries are in the business of export and import of drugs and patent medicines, medical supplies with pharmacy depot operations and also organize distribution channels between drug manufacturers, hospitals, and pharmacies. The company also distributes cosmetics, personal care, infant food, vitamins, medical and similar products.
79GF Score

Get the complete analysis for IST:SELEC

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺223.00
Price
₺87.25
GF Value